<DOC>
	<DOCNO>NCT01419600</DOCNO>
	<brief_summary>The purpose study assess safety , tolerability , pharmacokinetics pharmacodynamics increase single dos AZD8683 administer via inhalation</brief_summary>
	<brief_title>To Assess Safety , Tolerability , Pharmacokinetics , Pharmacodynamics Single Ascending Doses Inhaled AZD8683</brief_title>
	<detailed_description>A Phase I , Single Centre , Double-blind , Randomised , Placebo-controlled , Parallel-group Study Assess Safety , Tolerability , Pharmacokinetics Pharmacodynamics inhale AZD8683 Single Ascending Doses administer via Turbuhaler Healthy Subjects</detailed_description>
	<criteria>Provision sign date , write informed consent prior study specific procedure Healthy male subject age 18 45 year suitable vein cannulation repeat venepuncture Male subject willing use barrier contraception ie , condom spermicide , day dose least 3 month dose investigational product Have body mass index ( BMI ) 19 30 kg/m2 inclusive weigh least 50 kg 100 kg inclusive History presence gastrointestinal , pulmonary , hepatic renal disease condition know interfere absorption , distribution , metabolism excretion drug Any clinically significant illness , medical/surgical procedure trauma within 4 week first administration investigational product Abnormal vital sign , 10 minute supine rest , define follow : Systolic blood pressure &gt; 140 mm Hg Diastolic blood pressure &gt; 90 mm Hg Heart rate &lt; 40 &gt; 85 beat per minute Any clinically important abnormality rhythm , conduction morphology rest ECG . This include subject follow : PR ( PQ ) interval prolongation &gt; 200 m drop beat ( single non conduct Pwaves ) base screen Prolonged QTcF &gt; 450 m shorten QTcF &lt; 340 m family history long QT syndrome</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Phase 1</keyword>
	<keyword>healthy volunteer</keyword>
	<keyword>safety</keyword>
	<keyword>tolerability</keyword>
	<keyword>pharmacokinetics</keyword>
	<keyword>single ascend dose study</keyword>
</DOC>